{"id":"https://openalex.org/W7225623137","doi":"https://doi.org/10.3389/fendo.2026.1944597","title":"Adjunctive pharmacotherapy for obesity in type 1 diabetes: current evidence for GLP-1 receptor agonists","display_name":"Adjunctive pharmacotherapy for obesity in type 1 diabetes: current evidence for GLP-1 receptor agonists","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225623137","doi":"https://doi.org/10.3389/fendo.2026.1944597"},"language":"en","primary_location":{"id":"doi:10.3389/fendo.2026.1944597","doi":"https://doi.org/10.3389/fendo.2026.1944597","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fendo.2026.1944597","pdf_url":"https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2026.1944597/pdf","source":{"id":"https://openalex.org/S2597401208","display_name":"Frontiers in Endocrinology","issn_l":"1664-2392","issn":["1664-2392"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Endocrinology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2026.1944597/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057650988","display_name":"Maja Bareti\u0107","orcid":"https://orcid.org/0000-0002-7242-8407","observed_orcids":["https://orcid.org/0000-0002-7242-8407"]},"institutions":[{"id":"https://openalex.org/I138937732","display_name":"University Hospital Centre Zagreb","ror":"https://ror.org/00r9vb833","country_code":"HR","type":"healthcare","lineage":["https://openalex.org/I138937732"]},{"id":"https://openalex.org/I181343428","display_name":"University of Zagreb","ror":"https://ror.org/00mv6sv71","country_code":"HR","type":"education","lineage":["https://openalex.org/I181343428"]}],"countries":["HR"],"is_corresponding":true,"raw_author_name":"Maja Bareti\u0107","raw_affiliation_strings":["Department of Internal Medicine, School of Medicine, University of Zagreb","Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital Centre Zagreb"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, School of Medicine, University of Zagreb","institution_ids":["https://openalex.org/I181343428"]},{"raw_affiliation_string":"Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital Centre Zagreb","institution_ids":["https://openalex.org/I138937732"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034544264","display_name":"Andrej Belan\u010di\u0107","orcid":"https://orcid.org/0000-0001-7848-6600","observed_orcids":["https://orcid.org/0000-0001-7848-6600"]},"institutions":[{"id":"https://openalex.org/I154347574","display_name":"University of Rijeka","ror":"https://ror.org/05r8dqr10","country_code":"HR","type":"education","lineage":["https://openalex.org/I154347574"]}],"countries":["HR"],"is_corresponding":false,"raw_author_name":"Andrej Belan\u010di\u0107","raw_affiliation_strings":["Department of Basic and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Rijeka"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Basic and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Rijeka","institution_ids":["https://openalex.org/I154347574"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5057650988"],"corresponding_institution_ids":["https://openalex.org/I138937732","https://openalex.org/I181343428"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.7505000233650208,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.7505000233650208,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.210099995136261,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.022099999710917473,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-1-diabetes","display_name":"type 1 diabetes","score":0.949999988079071},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.9829999804496765},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9679999947547913},{"id":"https://openalex.org/keywords/gip-glp-1-receptor-agonist","display_name":"GIP/GLP-1 receptor agonist","score":0.9900000095367432},{"id":"https://openalex.org/keywords/adjunctive-pharmacotherapy","display_name":"adjunctive pharmacotherapy","score":0.9769999980926514},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.9139999747276306},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.6510000228881836},{"id":"https://openalex.org/keywords/appetite-suppression","display_name":"appetite suppression","score":0.8100000023841858},{"id":"https://openalex.org/keywords/gastric-emptying","display_name":"gastric emptying","score":0.7590000033378601},{"id":"https://openalex.org/keywords/glucagon-secretion","display_name":"glucagon secretion","score":0.8859999775886536},{"id":"https://openalex.org/keywords/insulin-sensitivity","display_name":"insulin sensitivity","score":0.7609999775886536},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.800000011920929}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8331999778747559},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6148999929428101},{"id":"https://openalex.org/C3020000205","wikidata":"https://www.wikidata.org/wiki/Q2412849","display_name":"Narrative review","level":2,"score":0.5570999979972839},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.550000011920929},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.5396000146865845},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.5353999733924866},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.5350000262260437},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.4657000005245209},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.43849998712539673},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.43689998984336853},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.4284000098705292},{"id":"https://openalex.org/C3018162438","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Adjunctive treatment","level":2,"score":0.4244999885559082},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4196999967098236},{"id":"https://openalex.org/C2779952866","wikidata":"https://www.wikidata.org/wiki/Q6746705","display_name":"Management of obesity","level":4,"score":0.40139999985694885},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3882000148296356},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.365200012922287},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.35280001163482666},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.3395000100135803},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.33309999108314514},{"id":"https://openalex.org/C75908981","wikidata":"https://www.wikidata.org/wiki/Q28578","display_name":"Appetite","level":2,"score":0.3240000009536743},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32120001316070557},{"id":"https://openalex.org/C140608501","wikidata":"https://www.wikidata.org/wiki/Q7318358","display_name":"Review article","level":2,"score":0.299699991941452},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.2962000072002411},{"id":"https://openalex.org/C2780780548","wikidata":"https://www.wikidata.org/wiki/Q424163","display_name":"Orlistat","level":4,"score":0.2815000116825104},{"id":"https://openalex.org/C12713177","wikidata":"https://www.wikidata.org/wiki/Q1900281","display_name":"Perspective (graphical)","level":2,"score":0.28049999475479126},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.27489998936653137},{"id":"https://openalex.org/C34320749","wikidata":"https://www.wikidata.org/wiki/Q17087302","display_name":"Weight management","level":4,"score":0.26269999146461487},{"id":"https://openalex.org/C2781232474","wikidata":"https://www.wikidata.org/wiki/Q124407","display_name":"Type 1 diabetes","level":3,"score":0.2581999897956848},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2563999891281128},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2526000142097473}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3389/fendo.2026.1944597","doi":"https://doi.org/10.3389/fendo.2026.1944597","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fendo.2026.1944597","pdf_url":"https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2026.1944597/pdf","source":{"id":"https://openalex.org/S2597401208","display_name":"Frontiers in Endocrinology","issn_l":"1664-2392","issn":["1664-2392"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Endocrinology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3389/fendo.2026.1944597","doi":"https://doi.org/10.3389/fendo.2026.1944597","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fendo.2026.1944597","pdf_url":"https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2026.1944597/pdf","source":{"id":"https://openalex.org/S2597401208","display_name":"Frontiers in Endocrinology","issn_l":"1664-2392","issn":["1664-2392"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Endocrinology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225623137.pdf","grobid_xml":"https://content.openalex.org/works/W7225623137.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W2160945140","https://openalex.org/W2168602329","https://openalex.org/W2514658869","https://openalex.org/W2769105409","https://openalex.org/W2895135221","https://openalex.org/W2895666357","https://openalex.org/W3034802927","https://openalex.org/W4385999131","https://openalex.org/W4391569405","https://openalex.org/W4393932284","https://openalex.org/W4399671023","https://openalex.org/W4406231961","https://openalex.org/W4411980278","https://openalex.org/W4412932174","https://openalex.org/W4416430259","https://openalex.org/W4417121401","https://openalex.org/W7139117505","https://openalex.org/W7160501480","https://openalex.org/W7163692800"],"related_works":["https://openalex.org/W4406686063","https://openalex.org/W4205144121","https://openalex.org/W4405946134","https://openalex.org/W7163012374","https://openalex.org/W4405658098","https://openalex.org/W2588693072","https://openalex.org/W4387582042","https://openalex.org/W7141612855","https://openalex.org/W7224093906","https://openalex.org/W7217665367"],"abstract_inverted_index":{"The":[0,113],"increasing":[1],"prevalence":[2],"of":[3,73,93,125,134],"obesity":[4,109],"among":[5],"individuals":[6],"with":[7,90,161],"type":[8,58],"1":[9],"diabetes":[10,60],"(T1D)":[11],"has":[12],"introduced":[13],"significant":[14],"metabolic":[15],"complexity,":[16],"including":[17,116],"insulin":[18,24,79],"resistance,":[19],"weight-related":[20],"comorbidities,":[21],"and":[22,47,61,76,100,130,155,163],"escalating":[23],"requirements.":[25],"Traditional":[26],"insulin-centric":[27],"management":[28,110],"strategies":[29],"often":[30],"exacerbate":[31],"weight":[32],"gain,":[33],"highlighting":[34],"the":[35,94,123,131,135,139],"need":[36],"for":[37,108],"adjunctive":[38,106],"pharmacological":[39],"approaches.":[40],"Glucagon-like":[41],"peptide-1":[42],"receptor":[43,50],"agonists":[44],"(GLP-1":[45],"RAs)":[46],"dual":[48,101],"GLP-1/GIP":[49,53,102],"agonist":[51],"(dual":[52],"RA),":[54],"widely":[55],"used":[56],"in":[57,78,111,122,142,159],"2":[59],"obesity,":[62],"offer":[63],"mechanistic":[64],"benefits":[65],"through":[66],"appetite":[67],"suppression,":[68],"delayed":[69],"gastric":[70],"emptying,":[71],"modulation":[72],"glucagon":[74],"secretion,":[75],"improvement":[77],"sensitivity.":[80],"This":[81],"narrative":[82],"perspective":[83],"combines":[84],"a":[85],"single":[86],"clinical":[87,118,157],"case":[88],"report":[89],"an":[91],"overview":[92],"available":[95,114],"evidence":[96,136,141],"on":[97],"GLP-1":[98],"RAs":[99,103],"as":[104],"emerging":[105],"therapies":[107],"T1D.":[112],"evidence,":[115],"our":[117],"experience,":[119],"is":[120],"considered":[121],"context":[124],"potential":[126],"benefits,":[127],"safety":[128],"considerations,":[129],"current":[132],"limitations":[133],"base.":[137],"Given":[138],"limited":[140],"T1D,":[143],"further":[144],"well-designed":[145],"studies":[146],"are":[147],"needed":[148],"to":[149],"better":[150],"define":[151],"their":[152],"efficacy/effectiveness,":[153],"safety,":[154],"appropriate":[156],"use":[158],"people":[160],"T1D":[162],"obesity.":[164]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}